SCHEMBL5145492

SCHEMBL5145492

NC(=O)c1ccc(-n2c3c(c4ccccc42)/C(=N/O)CCC3)c(Br)c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 4/20 0.35
HDAC6 Q9UBN7 4/20 0.35
NPC1 O15118 2/20 0.34
MAPK1 P28482 3/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
FABP4 P15090 1/20 0.32
HTR2A P28223 1/20 0.32
HTR2C P28335 1/20 0.32
RXRA P19793 1/20 0.31
HDAC10 Q969S8 1/20 0.31
HSD17B3 P37058 1/20 0.31
TSHR P16473 2/20 0.31
UBE2N P61088 1/20 0.31
HDAC8 Q9BY41 2/20 0.30
HDAC3 O15379 1/20 0.30
CYP2C19 P33261 1/20 0.30
HDAC4 P56524 1/20 0.30
HDAC7 Q8WUI4 1/20 0.30
HDAC2 Q92769 1/20 0.30
HDAC11 Q96DB2 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5145496 1.00 HDAC1 (0.35) HDAC1HDAC6NPC1MAPK1SMN1; SMN2
SCHEMBL14422441 0.87 MYC (0.35) HDAC1HDAC6NPC1MAPK1SMN1; SMN2
SCHEMBL5147102 0.86 HDAC1 (0.48) HDAC1HDAC6NPC1MAPK1SMN1; SMN2
SCHEMBL5147159 0.78 HDAC1 (0.45) HDAC1HDAC6NPC1MAPK1RXRA
SCHEMBL5145359 0.76 GRM4 (0.35) NPC1MAPK1SMN1; SMN2KDM4EALDH1A1
SCHEMBL5145355 0.76 GRM4 (0.35) NPC1MAPK1SMN1; SMN2KDM4EALDH1A1
SCHEMBL5145477 0.73 HDAC1 (0.46) HDAC1HDAC6NPC1SMN1; SMN2HSD17B3
SCHEMBL5147126 0.73 HDAC1 (0.46) HDAC1HDAC6NPC1HSD17B3KDM4E
SCHEMBL5147078 0.73 HDAC1 (0.48) HDAC1HDAC6NPC1HDAC10HSD17B3
SCHEMBL5147069 0.72 HDAC1 (0.44) HDAC1HDAC6NPC1MAPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US claimed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
US-20070185184-A1 Carbazole derivatives SERENEX, INC. 2007-08-09 US disclosed
WO-2007035620-A2 CARBAZOLE DERIVATIVES SERENEX, INC. (US) 2007-03-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185184-A1 Carbazole derivatives CCNI, MKI67, CCNB3 HDAC1 145/4885HDAC6 204/4885NPC1 2015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.